Hypertension
Conditions
Keywords
aerobic exercise, quality of life, hypertension, Muscle Relaxation
Brief summary
The study is a randomized controlled trial. The purpose of study is to compare the additive effects of Jacobson's progressive muscle relaxation technique with aerobic exercise versus aerobic exercise on cardiopulmonary parameters including systolic and diastolic blood pressure, heart rate, respiratory rate, rate pressure product and quality of life in stage 1 hypertensive individuals.
Detailed description
The study will consist of referred stage 1 hypertensive patients by medical specialist/cardiologist. Participants will be screened through PAR-Q and IPAQ Questionnaire. Cardiac monitor will be used for assessing the cardiopulmonary parameters. SF-36 Questionnaire will be used for assessing the quality of life. Informed written consent will be taken after which participants will be recruited into two groups. Control group will be provided aerobic exercise while interventional group will be provided Jacobson's progressive muscle relaxation technique with aerobic exercise. Outcome measures assessment will be done at pre-session, at 2 weeks and after 4 weeks post-intervention
Interventions
Jacobaon's progressive muscle relaxation technique for 15 minutes Total duration: 45 minutes
Participants in this group will only be provided aerobic exercise for 4 weeks supervised by physiotherapist. Aerobic Exercise include the following: * Warm up exercises for 5 minutes. * Brisk walking on treadmill for 25 minutes which include warm up period for 10 minutes then 14 minutes brisk walk and cool down period included 1 minute walk. * Stepper for 5 minutes. * Static cycling for 5 minutes. * Cool down for 5 minutes. Week 03 and Week 04: Frequency: 5 days per week Intensity: 60-80% Target heart rate Time: 45 minutes Week 01 and Week 02: Frequency: 5 days per week Intensity: 50-60 % Target heart rate Time: 45 minutes
Sponsors
Study design
Eligibility
Inclusion criteria
* Adults: aged (18-45 years) * Gender: both male and female * Patients diagnosed with stage 1 hypertension (130-139 / 80-89 mmHg according to AHA/ACC 2017 guidelines * Mild to moderate physical activity level on IPAQ Questionnaire * Individuals who are able to understand and follow the instructions for exercise
Exclusion criteria
* Unstable angina, MI, heart failure, advanced CAD patients * Severe neurological, musculoskeletal, or gynaecological conditions which limit participation in study * Recent history of fracture * Morbidly obese (BMI \> 40.0 kg / m2)
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Systolic and diastolic blood pressure | 04 Weeks | Evaluation will be done using cardiac monitor for blood pressure. |
| Heart rate | 04 Weeks | It will be measured through pulse oximeter. |
| Respiratory rate | 04 Weeks | It will be measured by counting the number of breaths a person takes per minute |
| Rate pressure product | 04 Weeks | It will be calculated by multiplying heart rate with systolic blood pressure |
Countries
Pakistan